Description: At Nutriband and our subsidiaries, our core focus is to use innovative drug delivery systems and devices to improve patient outcomes, specifically…
pharmaceutical products (65) patient focused (10) transdermal technologies (1)
Home About Menu Toggle Management Board of Directors Advisory Board Careers Nutriband Costa Rica Investors Pipeline Capabilities News Contact Us Innovative Transdermal Technologies and Patient Focused Pharmaceutical products Learn More About Us At Nutriband and our subsidiaries, our core focus is to use innovative drug delivery systems and devices to improve patient outcomes, specifically targeting the Global Opioid epidemic. Fentanyl and other opioid based transdermal medications unfortunately play a role
Through our Clinical Subsidiary 4P Therapeutics,Our Company has capabilities for developing pharmaceutical products from pre-clinical testing to clinical manufacturing and early stage clinical development (Phase I/II). A key company focus and area of expertise at 4P is in the development of transdermal products for currently injected compounds, including proteins, peptides, macromolecules and biologics. Transdermal delivery of commercially available drugs or biologics that are typically delivered via inject
Its our goal to improve patient comfort, safety and efficacy while setting new safety standards for notoriously abused, yet extremely effective medications!
Industry Clusters | Florida High Tech Corridor
4P Therapeutics
Cenfluence | Central Florida Cluster Initiative in and around Metro Orlando
Mission Investor Relations - Targeted Strategies for Today's Evolving MarketsMission Investor Relations | Targeted Strategies fo